Kenneth Hoberman, Chief Operating Officer at STEMLINE THERAPEUTICS INC (STML), sold 52,592 shares at $11.85 ($623K) on 2018-11-26, disclosed to the SEC on 2018-11-30.
Open-market sale of $623k STML by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.85 | 26,296 | $312K | 50.0% |
| 2 | $11.85 | 26,296 | $312K | 50.0% |
| Total | $11.85 avg | 52,592 | $623K | 100% |
| Filing → |
| STML | SELL | 2020-02-28 | $148K | — | Filing → |
| STML | SELL | 2020-01-24 | $311K | — | Filing → |
| STML | SELL | 2020-01-10 | $274K | — | Filing → |